secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001104659-24-095276
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel receives Nasdaq delisting notice for equity deficiency; hearing set for Oct 15, 2024
--------------------------------------------------------------------------------

- Nasdaq Staff determined Cyclacel's stockholders' equity was below $2.5M as of June 30, 2024, violating Listing Rule 5550(b)(1).
- Company requested a hearing before Nasdaq Hearings Panel, automatically staying any suspension or delisting pending decision.
- Hearing scheduled for October 15, 2024; company will present plan to regain compliance with equity rule.
- No assurance that hearing will be successful or that company can maintain compliance if listing continues.
- If appeal denied or compliance not regained, common and preferred stock subject to delisting from Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924095276/0001104659-24-095276-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924095276/tm2423119d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-095276

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer